This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Deep Dive into FDA’s Expedited Programs for Drug Development
Published on: Mar 18th, 2020
If you are developing products for serious and life-threatening illnesses with unmet medical needs, there are several mechanisms offered by FDA that can accelerate your product development and the review of your BLA/NDA.
This webinar will provide you some background on each of the tools and how you can leverage them to your advantage. The tools include – Fast Track (FTD), Breakthrough Therapy Designation (BTD), Regenerative Medicine and Advanced Therapies (RMAT), accelerated approval and priority review.
Some key learning points:
- Understand various mechanisms created by FDA to speed the product development and the BLA/NDA review
- Comprehend the types of situation to which these tools are applicable
- Familiar with the differences in the requirements to obtain each tool
SAMPLE OF THE PRESENTATION
Access the full webinar replay now
Fill in the form to download the content